“…Given these characteristics, TL has been used as an indicator of biological aging and neurological wellbeing, and studies have intricately connected individual telomere pathophysiology to disease prognosis and therapeutic efficacy (Cassidy et al, ; Klapper et al, ). Of particular importance, epidemiological studies have linked telomere shortening to ACEs (Chen et al, ), sleep disturbances (Jackowska et al, ; James et al, ), as well as pain thresholds and sensitivity in chronic pain patients (Hassett et al, ). Interestingly, we would have predicted that early life stress, SD, and surgery, would have reduced TL, but we found the opposite; TL was actually increased in MS groups.…”